MAD-bisphosphonate therapy

N/A

Report date: 2025/06/11 10:27:39

Base Information

Drug NameMAD-bisphosphonate therapy
Drug Alias NameCD206 receptor targeting (Navidea Biopharmaceuticals)
ClassificationBiologics
Mechanisms of ActionMacrophage mannose receptor 1 modulators
TargetsMacrophage mannose receptor 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNavidea Biopharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesNavidea Biopharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A